Clinicopathological Correlates of Ocular Surface Squamous Neoplasia.

Clinical risk factors Clinicopathological correlates Ocular surface squamous neoplasia Patient outcomes

Journal

Ocular oncology and pathology
ISSN: 2296-4681
Titre abrégé: Ocul Oncol Pathol
Pays: Switzerland
ID NLM: 101656139

Informations de publication

Date de publication:
Jun 2024
Historique:
received: 15 11 2023
accepted: 02 03 2024
medline: 17 6 2024
pubmed: 17 6 2024
entrez: 17 6 2024
Statut: ppublish

Résumé

This study examined the distribution of histopathological disease severity amongst a cohort of patients treated for clinically suspected ocular surface squamous neoplasia and evaluated the relationship between various patient and clinical factors and the severity of pathological grade as well as treatment outcomes. A retrospective cohort study of demographic and clinicopathological factors of 150 patients clinically diagnosed with suspected ocular surface squamous neoplasia who underwent excision of lesion with histopathological diagnosis. The study included 125 cases; the mean age at diagnosis was 64 years (SD = 11.26). 74% of cases were histologically confirmed as ocular surface squamous neoplasia. Pathological distribution was conjunctival intraepithelial neoplasia I (13.6%), conjunctival intraepithelial neoplasia II (16.8%), conjunctival intraepithelial neoplasia III (21.6%), carcinoma in situ (21.6%), and squamous cell carcinoma (2.4%). Lesion appearance was leukoplakic (18%), gelatinous (15%), dysplastic (11%), vascular (6%), papilliform (2%), nodular (2%). Lesion location was nasal (43%), temporal (42%), and superior or inferior (14%). Recurrence occurred in 7 cases (5.6%). A significant association was found between presence of leukoplakia and pathological grade ( Ocular surface squamous neoplasia is most frequently diagnosed in conjunctival intraepithelial neoplasia III and carcinoma in situ stages, and treatment outcomes are usually favourable.

Identifiants

pubmed: 38882020
doi: 10.1159/000538174
pii: 538174
pmc: PMC11178340
doi:

Types de publication

Journal Article

Langues

eng

Pagination

88-97

Informations de copyright

© 2024 S. Karger AG, Basel.

Déclaration de conflit d'intérêts

The authors have no conflicts of interest to declare.

Auteurs

Timothy Kalas (T)

Department of Ophthalmology, Royal Brisbane and Women's Hospital, Herston, QLD, Australia.

Dimitrios Vagenas (D)

Faculty of Health, School of Public Health and Social Work, Queensland University of Technology, Brisbane, QLD, Australia.

Luke Maccheron (L)

Department of Ophthalmology, Royal Brisbane and Women's Hospital, Herston, QLD, Australia.
Brisbane North Eye Centre, Chermside, QLD, Australia.

Nicholas Toalster (N)

Department of Ophthalmology, Royal Brisbane and Women's Hospital, Herston, QLD, Australia.

Classifications MeSH